Patients taking narrow therapeutic index drugs may require monitoring because small differences in blood concentration could cause:

Drug-disease contraindications refer to situations where a drug should not be used in the presence of a specific disease due to the potential for harm. While these contraindications are critical in prescribing practices, they are not directly related to the blood concentration of NTI drugs. Monitoring is primarily focused on managing dosing to avoid toxicity or ineffective treatment rather than contraindications based on patient disease states.

Chemical incompatibilities occur when two or more substances react adversely with each other, often affecting drug formulation or administration. This concern is more relevant in the context of drug preparation and interaction rather than blood concentration levels. Monitoring for NTI drugs does not specifically address chemical incompatibilities but rather focuses on maintaining therapeutic levels to avoid adverse effects.

Anaphylactic shock is a severe allergic reaction that can occur in response to certain drugs but is not specifically tied to blood concentration levels. While NTI drugs can potentially cause allergic reactions, the immediate concern with these medications relates more to their therapeutic window than to the risk of anaphylaxis, which is a different mechanism of drug reaction.